The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels

References

• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;74(10):1376–1414. doi:10.1016/j.jacc.2019.03.009
   PubMed Web of Science ®Google Scholar
• Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.
   PubMed Web of Science ®Google Scholar
• Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
   PubMedGoogle Scholar
• Cho Y, Shimura S, Aki A, et al. The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions. Interact Cardiovasc Thorac Surg. 2016;23(1):125–132. doi:10.1093/icvts/ivw057
   PubMed Web of Science ®Google Scholar
• Ikeno F, Brooks MM, Nakagawa K, et al. SYNTAX Score and Long-Term Outcomes. J Am Coll Cardiol. 2017;69(4):395–403. doi:10.1016/j.jacc.2016.10.067
   PubMed Web of Science ®Google Scholar
• Karabag Y, Rencuzogullari I, Cagdas M, et al. Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. Int J Cardiovasc Imaging. 2019;35(1):1–7. doi:10.1007/s10554-018-1446-6
   PubMedGoogle Scholar
• Xu N, Tang X-F, Yao Y, et al. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention. Nutrition, Metabolism and Cardiovascular Diseases. 2020;30(2):265–273. doi:10.1016/j.numecd.2019.09.020
   PubMedGoogle Scholar
• Ashfaq F, Goel PK, Moorthy N, et al. Lipoprotein (A) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India. Sultan Qaboos Univ Med J. 2012;12(4):465–472. doi:10.12816/0003172
   PubMedGoogle Scholar
• Liu Y, Ma H, Zhu Q, et al. A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population. J Lipid Res. 2019;60(8):1440–1448. doi:10.1194/jlr.P091009
   PubMedGoogle Scholar
• Dai W, Long J, Cheng Y, et al. Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease. Sci Rep. 2018;8(1):7726.
   PubMedGoogle Scholar
• Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–1086. doi:10.1016/j.hlc.2016.02.023
   PubMed Web of Science ®Google Scholar
• Yang Y-L, Wu C-H, Hsu P-F, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Tsimikas SA. A Test in Context: lipoprotein(a). J Am Coll Cardiol. 2017;69(6):692–711. doi:10.1016/j.jacc.2016.11.042
   PubMed Web of Science ®Google Scholar
• Willeit P, Kiechl S, Kronenberg F, et al. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol. 2014;64(9):851–860. doi:10.1016/j.jacc.2014.03.061
   PubMed Web of Science ®Google Scholar
• Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–423.
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Gregoire J, Pearson GJ, et al. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016;32(11):1263–1282. doi:10.1016/j.cjca.2016.07.510
   PubMed Web of Science ®Google Scholar
• Ma Y, Rao J, Long J, et al. Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39(2):235–240.
   PubMedGoogle Scholar
• Zhou B-Y, Sun D, Wang C, et al. Plasma lipoprotein(a) concentration is associated with the coronary severity but not with events in stable coronary artery disease patients: A Chinese cohort study. Heart Lung Circ. 2019;28(7):1009–1017. doi:10.1016/j.hlc.2018.05.190
   PubMedGoogle Scholar
• Chieng D, Pang J, Ellis KL, et al. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease. J Clin Lipidol. 2018;12(4):1019–1026. doi:10.1016/j.jacl.2018.03.090
   PubMedGoogle Scholar
• Cantin B, Gagnon F, Moorjani S, et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol. 1998;31(3):519–525. doi:10.1016/S0735-1097(97)00528-7
   PubMedGoogle Scholar
• O’Donoghue ML, Morrow DA, Tsimikas S, et al. Lipoprotein(a) for risk assessment in patients with established coronary artery disease. J Am Coll Cardiol. 2014;63(6):520–527. doi:10.1016/j.jacc.2013.09.042
   PubMed Web of Science ®Google Scholar
• Yeang C, Witztum JL, Tsimikas S. ‘LDL-C’ = LDL-C + Lp(a)-C. Curr Opin Lipidol. 2015;26(3):169–178. doi:10.1097/MOL.0000000000000171
   PubMed Web of Science ®Google Scholar
• Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clinical Science. 2018;132(12):1243–1252. doi:10.1042/CS20180306
   PubMed Web of Science ®Google Scholar
• Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(7):483–495. doi:10.7326/0003-4819-151-7-200910060-00009
   PubMed Web of Science ®Google Scholar
• Xing Y, Guo J-T, Gai L-Y, et al. Association of uric acid and C-reactive protein with the severity of coronary artery disease Using SYNTAX score and clinical SYNTAX score. Heart Surg Forum. 2019;22(3):E247–E252. doi:10.1532/hsf.2397
   PubMedGoogle Scholar
• Karadeniz M, Duran M, Akyel A, et al. High sensitive CRP level is associated with intermediate and high syntax score in patients with acute coronary syndrome. Int Heart J. 2015;56(4):377–380. doi:10.1536/ihj.14-299
   PubMed Web of Science ®Google Scholar
• Liu Y, Jia S-D, Yao Y, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2020;75(1):60–65. doi:10.1016/j.jjcc.2019.06.012
   PubMedGoogle Scholar
• Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619–1625. doi:10.1007/s11255-014-0730-1
   PubMed Web of Science ®Google Scholar
• Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375–383. doi:10.2217/bmm-2015-0050
   PubMed Web of Science ®Google Scholar
• Kundi H, Kiziltunc E, Cetin M, et al. Zusammenhang des Monozyten-/HDL-C-Quotienten mit dem SYNTAX-Score bei Patienten mit stabiler koronarer Herzkrankheit. Herz. 2016;41(6):523–529. doi:10.1007/s00059-015-4393-1
   PubMedGoogle Scholar
• Xu W, Guan H, Gao D, et al. Sex-specific association of monocyte count to high-density lipoprotein ratio with SYNTAX score in patients with suspected stable coronary artery disease. Medicine. 2019;98(41):e17536. doi:10.1097/MD.0000000000017536
   PubMedGoogle Scholar
• Huang J, Zhang Q, Wang R, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monitor. 2019;25:9690–9701. doi:10.12659/MSM.919802
   PubMed Web of Science ®Google Scholar